Novo Holdings Seagen Inc. Transaction History

Novo Holdings

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$187.64 - $206.25 $4.69 Million - $5.16 Million	25,000 Added 18.52%	159,986 $30.8 Million
Q1 2023 May 15, 2023	SELL	$127.59 - $203.08 $9.57 Million - $15.2 Million	-75,014 Reduced 35.72%	134,986 $27.3 Million
Q4 2022 Feb 14, 2023	BUY	$117.37 - $139.17 $15.8 Million - $18.8 Million	135,000 Added 180.0%	210,000 $27 Million
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $10.1 Million - $13.5 Million	75,000 New	75,000 $10.3 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

Stay updated on Novo Holdings with notifications on news.